首页 | 本学科首页   官方微博 | 高级检索  
检索        

99Tcm-HL91肺癌显像评估非小细胞肺癌放射治疗敏感性的临床价值
引用本文:付鹏,赵长久,杨志杰.99Tcm-HL91肺癌显像评估非小细胞肺癌放射治疗敏感性的临床价值[J].哈尔滨医科大学学报,2004,38(6):558-560,563.
作者姓名:付鹏  赵长久  杨志杰
作者单位:哈尔滨医科大学第一临床医学院,核医学科,黑龙江,哈尔滨,150001
摘    要:目的探讨99Tcm-HL91肺癌显像评估非小细胞肺癌放射治疗敏感性的临床价值.方法对33例拟进行放射治疗的非小细胞肺癌患者静脉注射99Tcm-HL91后4h(早期相)、24h(延迟相)进行断层显像,在断层图像上勾画肿瘤区及对侧正常肺组织的感兴趣区,计算半定量指标早期相摄取比值(ER)及延迟相摄取比值(DR).根据放疗前后的CT影像将患者分为敏感组和不敏感组,将半定量指标与放疗前后的CT检查结果对照.结果肺鳞癌患者敏感组与不敏感组ER及DR值均有显著性差异(P<0.01),不敏感组ER及DR值明显高于敏感组,肺腺癌患者敏感组与不敏感组ER及DR值均无显著性差异(P>0.05),鳞癌患者ER及DR值明显高于腺癌(P<0.01).结论 99Tcm-HL91肺癌显像评估肺鳞癌患者放射治疗敏感性有较大价值,高ER及DR患者对放射治疗不敏感,而对腺癌患者价值有限.

关 键 词:肺癌  放射性核素显像  HL91  放射治疗
文章编号:1000-1905(2004)06-0558-03

The value of 99Tcm-HL91 lung carcinoma imaging for the evaluation of radiotherapeutic response in non-small cell lung cancer patients
FU Peng,ZHAO Chang-jiu,YANG Zhi-jie.The value of 99Tcm-HL91 lung carcinoma imaging for the evaluation of radiotherapeutic response in non-small cell lung cancer patients[J].Journal of Harbin Medical University,2004,38(6):558-560,563.
Authors:FU Peng  ZHAO Chang-jiu  YANG Zhi-jie
Abstract:Objective To investigate the value of 99Tc m-HL91 lung carcinoma imaging for the evaluation of radiotherapeutic response in non-small cell lung cancer patients.Methods Thirty-three patients with non-small cell lung cancer who will receive radiotherapy underwent lung tomography imaging at 4h(early imaging),24h(delayed imaging) after injection of 99Tc m-HL91.Region of interests(ROIS) were drawn in the tumor and contralateral position in the tomography to caculate the semiquantitative measurements of the early T/N ratio(ER) and delayed T/N ratio(DR).The patients were divided into responder group and non-responder group according to the CT imaging before radiotherapy and after radiotherapy.The semiquantitative measurements results were compared with the CT imaging.Results The ER,DR of lung squamous cell cancer in non-responder group were significantly higher than those in responder group(P<0.01).While between non-responder group and responder group,there were no significant differences of ER and DR in lung adenocarcinoma(P>0.05).The ER,DR in squamous cell cancer were significantly higher than those in adenocarcinoma(P<0.01).Conclusion 99Tc m-HL91 lung tomography imaging is very useful for evaluating the radiotherapeutic response in squamous cell cancer and higher ER and DR patients have poor response,while in adenocarcinoma,it has limited value.
Keywords:lung cancer  radionuclide imaging  HL91  radiotherapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号